Gimatecan exerts potent antitumor activity against gastric cancer in vitro and in vivo via AKT and MAPK signaling pathways

被引:0
|
作者
Zuhua Chen
Zhentao Liu
Wenwen Huang
Zhongwu Li
Jianling Zou
Jingyuan Wang
Xiaoting Lin
Beifang Li
Dongshao Chen
Yanting Hu
Jiafu Ji
Jing Gao
Lin Shen
机构
[1] Peking University Cancer Hospital & Institute,Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology
[2] Peking University Cancer Hospital & Institute,Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology
[3] Peking University Cancer Hospital & Institute,Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Surgery
关键词
Gimatecan; Patient-derived xenografts; Gastric cancer; MAPK pathway;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells
    Hiroaki Sugiyama
    Kenichiro Onuki
    Kazunori Ishige
    Nobue Baba
    Tetsuya Ueda
    Sachiko Matsuda
    Kaoru Takeuchi
    Masafumi Onodera
    Yasuni Nakanuma
    Masayuki Yamato
    Masakazu Yamamoto
    Ichinosuke Hyodo
    Junichi Shoda
    [J]. Journal of Gastroenterology, 2011, 46 : 779 - 789
  • [22] Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells
    Sugiyama, Hiroaki
    Onuki, Kenichiro
    Ishige, Kazunori
    Baba, Nobue
    Ueda, Tetsuya
    Matsuda, Sachiko
    Takeuchi, Kaoru
    Onodera, Masafumi
    Nakanuma, Yasuni
    Yamato, Masayuki
    Yamamoto, Masakazu
    Hyodo, Ichinosuke
    Shoda, Junichi
    [J]. JOURNAL OF GASTROENTEROLOGY, 2011, 46 (06) : 779 - 789
  • [23] Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo
    Yang, Huanjie
    Zhou, Ping
    Huang, Hongbiao
    Chen, Di
    Ma, Ningfang
    Cui, Qiuzhi Cindy
    Shen, Shouxing
    Dong, Weihua
    Zhang, Xiaoyan
    Lian, Wen
    Wang, Xuejun
    Dou, Q. Ping
    Liu, Jinbao
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (10) : 2450 - 2459
  • [24] Afrormosin exerts an anticancer effect via MAPK and AKT signaling pathways in B16F10 cells
    Huiji Kim
    Minjoo Han
    Seong-Ah Shin
    Jangeun An
    Mi-Jeong Ahn
    Jun Hyuck Lee
    Hyun Ho Park
    Chang Sup Lee
    [J]. Applied Biological Chemistry, 2022, 65
  • [25] Afrormosin exerts an anticancer effect via MAPK and AKT signaling pathways in B16F10 cells
    Kim, Huiji
    Han, Minjoo
    Shin, Seong-Ah
    An, Jangeun
    Ahn, Mi-Jeong
    Lee, Jun Hyuck
    Park, Hyun Ho
    Lee, Chang Sup
    [J]. APPLIED BIOLOGICAL CHEMISTRY, 2022, 65 (01)
  • [26] Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathways
    Zhang, Qiang
    Wang, Xiaobing
    Cao, Shijie
    Sun, Yujie
    He, Xinya
    Jiang, Benke
    Yu, Yaqin
    Duan, Jingshi
    Qiu, Feng
    Kang, Ning
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2020, 128
  • [27] Salidroside protects against foam cell formation and apoptosis, possibly via the MAPK and AKT signaling pathways
    Ni, Jing
    Li, Yuanmin
    Li, Weiming
    Guo, Rong
    [J]. LIPIDS IN HEALTH AND DISEASE, 2017, 16
  • [28] Salidroside protects against foam cell formation and apoptosis, possibly via the MAPK and AKT signaling pathways
    Jing Ni
    Yuanmin Li
    Weiming Li
    Rong Guo
    [J]. Lipids in Health and Disease, 16
  • [29] Morusin exerts anti-cancer activity in renal cell carcinoma by disturbing MAPK signaling pathways
    Yang, Chengfei
    Luo, Jing
    Luo, Xing
    Jia, Weisheng
    Fang, Zhenqiang
    Yi, Shanhong
    Li, Longkun
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [30] Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo
    Vigushin, DM
    Ali, S
    Pace, PE
    Mirsaidi, N
    Ito, K
    Adcock, I
    Coombes, RC
    [J]. CLINICAL CANCER RESEARCH, 2001, 7 (04) : 971 - 976